The effect of citalopram in panic disorder

British Journal of Psychiatry

Volumn 170, Issue JUNE, 1997, Pages 549-553

  Wade, A G ^a   Lepola, U ^b   Koponen, H J ^c   Pedersen, V ^d   Pedersen, T ^d  

^a Physiotherapy Department   (United Kingdom)

^b Kuopion Psykiatripalvelu Oy   (Finland)

^c Moisio Hospital   (Finland)

^d H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NEUROTOXICITY; PANIC; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION; SEXUAL DYSFUNCTION;

EID: 0030805369     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.170.6.549     Document Type: Article

References (25)

1. Alexander, P. E. & Alexander, D. D. (1986) Alprazolam treatment for panic disorders. Journal of Clinical Psychiatry, 47, 301-304.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn. revised) (DSM - III - R).Washington, DC: APA.
3. _ (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington. DC: APA.
4. Andersch, S., Rosenberg, N. K., Kullingsjö, H., et al (1991) Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder: a Scandinavian multicentre study. Acta Psychiatrica Scandinavica, suppl. 365, 18-27.
5. Ballenger, J. C., Burrows, G. D., DuPont, R. L., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Archives of General Psychiatry, 25, 413-422.
6. Cross-National Collaborative Study (1992) Drug treatment of panic disorder. British Journal of Psychiatry, 160, 191-202.
7. Hamilton, M. (1959) The assessment of anxiety by rating. British Journal of Medical Psychology, 31, 50-55.
8. Hoehn-Saric, R., McLeod, D. R. & Hipsley, P. A. (1993) Effect of fluvoxamine on panic disorder. Journal of Clinical Psychopharmacology, 13, 321-326.
9. Humble, M. & Wistedt, B. (1992) Serotonin, panic disorder and agoraphobia: short term and long term efficacy of citalopram in panic disorders. International Clinical Psychopharmacology, suppl. 6, 21-39.
10. Hyttel, J., Arnt, J. & Sanchez, C. (1995) The pharmacology of citalopram. Reviews in Contemporary Pharmacotherapy, 6, 271-285.
11. Kahn, R. S. & van Praag, H. M. (1992) Panic disorder: a biological perspective. European Neuropsychopharmacology, 2, 1-20.
12. Lepola, U., Leinonen, E., Turtonen, J., et al (1994) The effect of citaiopram in panic disorder and agoraphobia: a pilot study. Nordic Journal of Psychiatry, 48, 13-17.
13. Maier, W. & Philipp, M. (1985) Comparative analysis of observer depression scales. Acta Psychiatrica Scandinavica, 72, 239-245.
14. _ , Buller, R., Philipp, M., et al (1988) The Hamilton Anxiety Scale: reliability, validity, and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders, 14, 61-68.
15. _ , Roth, S. M., Argyle, N., et al (1991) Avoidance behaviour: a predictor on the efficacy of pharmacotherapy in panic disorder. European Archives of Psychiatry and Clinical Neurosciences, 241, 151-158.
16. Marks, I. M., Swinson, R. P., Basoglu, M., et al (1991) Alprazolam and exposure alone and combined in panic disorder with agoraphobia. British Journal of Psychiatry, 162, 776-787.
17. Modigh, K., Westberg, P. & Erikkson, E. (1992) Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo controlled trial. Journal of Clinical Psychopharmacology, 12, 251-261.
18. Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
19. _ & Johnson, F. N. (1995) Citalopram in the treatment of depression. Reviews in Contemporary Pharmacotherapy, 6, 297-306.
20. Nutt, D. (1995) The role of SSRIs in anxiety disorders. European Neuropsychopharmacology, 5, 260-261.
21. Oehrberg, S., Christiansen, P. E., Behnke, K., et al (1995) Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo controlled study. British Journal of Psychiatry, 167, 374-379.
22. Sheehan, D. V. (1979) The Anxiety Disease. New York: Charles Scribner.
23. Snaith, R. P., Baugh, S. J., Clayden, A. D., et al (1982) The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. British Journal of Psychiatry, 141, 518-523.
24. Spier, S., Tesar, C., Rotenbaum, J., et al (1986) Clonazepam in the treatment of panic disorder and agoraphobia. Journal of Clinical Psychiatry, 47, 238-242.
25. World Health Organization (1989) WHO Adverse Reaction Terminology. Uppsala: WHO Collaborating Centre for Drug Monitoring.